Epygen Biotech Private Limited, a active private limited company, was established on 25 August 2011 in Rasayani, Maharashtra, India. Engaging in industrial enzymes & biochemicals within the manufacturing sector, it holds CIN: U24233MH2011PTC221254. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹19.55 Cr and a paid-up capital of ₹14.96 Cr.
It upholds a compliant status. Employing 47 professional, Its leadership includes Debayan Sukhamoy Ghosh (Director), Ineeyan Vivekanandan Ariyaratnam (Director), Soumitro Deb (Director). Past directors included Soumitro Deb, Sukhamoy Ghosh, Manickam. It holds ₹39.56 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. N-28/2, Additional Midc Patalganga, Taluka-Panvel, Rasayani, Maharashtra, 410220.
U24233MH2011PTC221254
221254
25 August 2011
₹19.55 Cr
₹14.96 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Epygen Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Debayan Sukhamoy Ghosh | Director | 25 Aug 2011 | Current |
| Ineeyan Vivekanandan Ariyaratnam | Director | 25 Aug 2011 | Current |
| Soumitro Deb | Director | 18 Mar 2020 | Current |
| Manickam | Director | 11 Jul 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 18 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Epygen Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 179.47% increase. The company also saw a substantial improvement in profitability, with a 66.14% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Epygen Biotech had a promoter holding of 74.66% and a public holding of 25.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹395,560,726.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2018 | Others | ₹11.78 Cr | Open |
| 29 Sep 2016 | Others | ₹27.78 Cr | Open |
Explore comprehensive loan charge details -
Epygen Biotech has a workforce of 47 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Epygen Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epygen Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Epygen Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Epygen Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others of Rs. 27.78 Cr registered on 29 Sep 2016 with Charge ID 100055184 was modified on 22 Jun 2021. was completed.
Soumitro Deb was appointed as a Director was appointed as a Director on 18 Mar 2020 & has been associated with this company since 5 years 8 months . was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 11.78 Cr with Charge ID 100219906 was registered on 07 Sep 2018. was documented.
The activity A charge with Others amounted to Rs. 27.78 Cr with Charge ID 100055184 was registered on 29 Sep 2016. was completed.
The CIN of Epygen Biotech Private Limited is U24233MH2011PTC221254.
Epygen Biotech Private Limited is headquartered at Plot No. N-28/2, Additional Midc Patalganga, Taluka-Panvel, Rasayani, Maharashtra, 410220.
Epygen Biotech Private Limited was incorporated on 25 August 2011.
The current directors of Epygen Biotech Private Limited are
The primary industry of Epygen Biotech Private Limited is Manufacturing.
Epygen Biotech Private Limited is unlisted.
The authorized capital of Epygen Biotech Private Limited is ₹19.55 Cr, and the paid-up capital is ₹14.96 Cr.
The compliance status of Epygen Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX